These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23886664)

  • 1. Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patients.
    Marston S; Memo M; Messer A; Papadaki M; Nowak K; McNamara E; Ong R; El-Mezgueldi M; Li X; Lehman W
    Hum Mol Genet; 2013 Dec; 22(24):4978-87. PubMed ID: 23886664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle myopathy mutations at the actin tropomyosin interface that cause gain- or loss-of-function.
    Memo M; Marston S
    J Muscle Res Cell Motil; 2013 Aug; 34(3-4):165-9. PubMed ID: 23719967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
    Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C
    Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital myopathies: diseases of the actin cytoskeleton.
    Clarkson E; Costa CF; Machesky LM
    J Pathol; 2004 Nov; 204(4):407-17. PubMed ID: 15495263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Primary Causes of Muscle Dysfunction Associated with the Point Mutations in Tpm3.12; Conformational Analysis of Mutant Proteins as a Tool for Classification of Myopathies.
    Borovikov YS; Karpicheva OE; Simonyan AO; Avrova SV; Rogozovets EA; Sirenko VV; Redwood CS
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant movement of β-tropomyosin associated with congenital myopathy causes defective response of myosin heads and actin during the ATPase cycle.
    Borovikov YS; Avrova SV; Rysev NA; Sirenko VV; Simonyan AO; Chernev AA; Karpicheva OE; Piers A; Redwood CS
    Arch Biochem Biophys; 2015 Jul; 577-578():11-23. PubMed ID: 25978979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms.
    Ochala J; Gokhin DS; Pénisson-Besnier I; Quijano-Roy S; Monnier N; Lunardi J; Romero NB; Fowler VM
    Hum Mol Genet; 2012 Oct; 21(20):4473-85. PubMed ID: 22798622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myopathy-causing Q147P TPM2 mutation shifts tropomyosin strands further towards the open position and increases the proportion of strong-binding cross-bridges during the ATPase cycle.
    Karpicheva OE; Simonyan AO; Kuleva NV; Redwood CS; Borovikov YS
    Biochim Biophys Acta; 2016 Mar; 1864(3):260-267. PubMed ID: 26708479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reason for the low Ca
    Avrova SV; Karpicheva OE; Rysev NA; Simonyan AO; Sirenko VV; Redwood CS; Borovikov YS
    Biochem Biophys Res Commun; 2018 Jul; 502(2):209-214. PubMed ID: 29792862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital myopathy-related mutations in tropomyosin disrupt regulatory function through altered actin affinity and tropomodulin binding.
    Moraczewska J; Robaszkiewicz K; Śliwinska M; Czajkowska M; Ly T; Kostyukova A; Wen H; Zheng W
    FEBS J; 2019 May; 286(10):1877-1893. PubMed ID: 30768849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype.
    Donkervoort S; Papadaki M; de Winter JM; Neu MB; Kirschner J; Bolduc V; Yang ML; Gibbons MA; Hu Y; Dastgir J; Leach ME; Rutkowski A; Foley AR; Krüger M; Wartchow EP; McNamara E; Ong R; Nowak KJ; Laing NG; Clarke NF; Ottenheijm C; Marston SB; Bönnemann CG
    Ann Neurol; 2015 Dec; 78(6):982-994. PubMed ID: 26418456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropomyosins in skeletal muscle diseases.
    Kee AJ; Hardeman EC
    Adv Exp Med Biol; 2008; 644():143-57. PubMed ID: 19209820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanochemical consequences of myopathy-linked mutations in Tpm2.2 on striated muscle contractility.
    Küçükdogru R; Franz P; Worch R; Robaszkiewicz K; Siatkowska M; Tsiavaliaris G; Moraczewska J
    FASEB J; 2024 Jan; 38(1):e23400. PubMed ID: 38156416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the rigor actin-tropomyosin-myosin complex.
    Behrmann E; Müller M; Penczek PA; Mannherz HG; Manstein DJ; Raunser S
    Cell; 2012 Jul; 150(2):327-38. PubMed ID: 22817895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms of Pathologies of Skeletal and Cardiac Muscles Caused by Point Mutations in the Tropomyosin Genes.
    Matyushenko AM; Levitsky DI
    Biochemistry (Mosc); 2020 Jan; 85(Suppl 1):S20-S33. PubMed ID: 32087052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations Q93H and E97K in
    Śliwinska M; Robaszkiewicz K; Wasąg P; Moraczewska J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of tropomyosin function and folding by a nemaline myopathy-causing mutation.
    Moraczewska J; Greenfield NJ; Liu Y; Hitchcock-DeGregori SE
    Biophys J; 2000 Dec; 79(6):3217-25. PubMed ID: 11106625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The primary cause of muscle disfunction associated with substitutions E240K and R244G in tropomyosin is aberrant behavior of tropomyosin and response of actin and myosin during ATPase cycle.
    Simonyan AO; Sirenko VV; Karpicheva OE; Robaszkiewicz K; Śliwinska M; Moraczewska J; Krutetskaya ZI; Borovikov YS
    Arch Biochem Biophys; 2018 Apr; 644():17-28. PubMed ID: 29510086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle weakness in TPM3-myopathy is due to reduced Ca2+-sensitivity and impaired acto-myosin cross-bridge cycling in slow fibres.
    Yuen M; Cooper ST; Marston SB; Nowak KJ; McNamara E; Mokbel N; Ilkovski B; Ravenscroft G; Rendu J; de Winter JM; Klinge L; Beggs AH; North KN; Ottenheijm CA; Clarke NF
    Hum Mol Genet; 2015 Nov; 24(22):6278-92. PubMed ID: 26307083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropomyosin 3 (TPM3) function in skeletal muscle and in myopathy.
    Lambert MR; Gussoni E
    Skelet Muscle; 2023 Nov; 13(1):18. PubMed ID: 37936227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.